Phase I study of autologous T cells bearing fully-humanized chimeric antigen receptors targeting mesothelin in mesothelin- expressing cancers (314)

Category Primary study
JournalGynecologic Oncology
Year 2022
This article has no abstract
Epistemonikos ID: 7960934ad4eb4675536740396aee3c17057bf9a0
First added on: Feb 15, 2025